{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:14:00Z","timestamp":1791288840450,"version":"4.3.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s12149-007-0094-z","type":"journal-article","created":{"date-parts":[[2008,5,23]],"date-time":"2008-05-23T12:24:12Z","timestamp":1211545452000},"page":"151-156","source":"Crossref","is-referenced-by-count":159,"title":["Low density of sigma1 receptors in early Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"22","author":[{"given":"Masahiro","family":"Mishina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei-ichi","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiichi","family":"Ishiwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,23]]},"reference":[{"key":"94_CR1","first-page":"3857","volume":"12","author":"K. Hashimoto","year":"2006","unstructured":"Hashimoto K, Ishiwata K. Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals. Curr Pharm Des 2006;12:3857\u20133876.","journal-title":"Curr Pharm Des"},{"key":"94_CR2","first-page":"355","volume":"42","author":"J.M. Walker","year":"1990","unstructured":"Walker JM, Bowen WD, Walker FO, Matsumoto RR, De Costa B, Rice KC. Sigma receptors: biology and function. Pharmacol Rev 1990;42:355\u2013402.","journal-title":"Pharmacol Rev"},{"key":"94_CR3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0165-6147(92)90030-A","volume":"13","author":"R. Quirion","year":"1992","unstructured":"Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio JM, Rothman RB, et al. A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 1992;13:85\u201386.","journal-title":"Trends Pharmacol Sci"},{"key":"94_CR4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1126\/science.2832949","volume":"240","author":"T.P. Su","year":"1988","unstructured":"Su TP, London ED, Jaffe JH. Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science (New York) 1988;240:219\u2013221.","journal-title":"Science (New York)"},{"key":"94_CR5","first-page":"187","volume":"7","author":"T.P. Su","year":"1993","unstructured":"Su TP. Delineating biochemical and functional properties of sigma receptors: emerging concepts. Critical Rev Neurobiol 1993;7:187\u2013203.","journal-title":"Critical Rev Neurobiol"},{"key":"94_CR6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0031-6865(99)00034-5","volume":"7","author":"W.D. Bowen","year":"2000","unstructured":"Bowen WD. Sigma receptors: recent advances and new clinical potentials. Pharm Acta Helv 2000;7:211\u2013218.","journal-title":"Pharm Acta Helv"},{"key":"94_CR7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-0173(01)00112-6","volume":"37","author":"T. Maurice","year":"2001","unstructured":"Maurice T, Urani A, Phan VL, Romieu P. The interaction between neuroactive steroids and the sigma1 receptor function: behavioral consequences and therapeutic opportunities. Brain Res Rev 2001;37:116\u2013132.","journal-title":"Brain Res Rev"},{"key":"94_CR8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0014-2999(02)02388-9","volume":"453","author":"M. Hiramatsu","year":"2002","unstructured":"Hiramatsu M, Hoshino T, Kameyama T, Nabeshima T. Involvement of kappa-opioid and sigma receptors in short-term memory in mice. Eur J Pharmacol 2002;453:91\u201398.","journal-title":"Eur J Pharmacol"},{"key":"94_CR9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-8993(94)91398-6","volume":"647","author":"T. Maurice","year":"1994","unstructured":"Maurice T, Hiramatsu M, Kameyama T, Hasegawa T, Nabeshima T. Behavioral evidence for a modulating role of sigma ligands in memory processes: II. Reversion of carbon monoxide-induced amnesia. Brain Res 1994;647:57\u201364.","journal-title":"Brain Res"},{"key":"94_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(96)00572-9","volume":"315","author":"T. Senda","year":"1996","unstructured":"Senda T, Matsuno K, Okamoto K, Kobayashi T, Nakata K, Mita S. Ameliorating effect of SA4503, a novel sigma1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. Eur J Pharmacol 1996;315:1\u201310.","journal-title":"Eur J Pharmacol"},{"key":"94_CR11","first-page":"851","volume":"265","author":"K. Matsuno","year":"1993","unstructured":"Matsuno K, Matsunaga K, Senda T, Mita S. Increase in extra-cellular acetylcholine level by sigma ligands in rat frontal cortex. J Pharmacol Exp Ther 1993;265:851\u2013859.","journal-title":"J Pharmacol Exp Ther"},{"key":"94_CR12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0006-8993(95)00618-Z","volume":"690","author":"K. Matsuno","year":"1995","unstructured":"Matsuno K, Senda T, Kobayashi T, Mita S. Involvement of sigma1 receptor in (+)-N-allylnormetazocine-stimulated hippocampal cholinergic functions in rats. Brain Res 1995;690:200\u2013206.","journal-title":"Brain Res"},{"key":"94_CR13","first-page":"106","volume":"279","author":"T. Kobayashi","year":"1996","unstructured":"Kobayashi T, Matsuno K, Nakata K, Mita S. Enhancement of acetylcholine release by SA4503, a novel sigma1 receptor agonist, in the rat brain. J Pharmacol Exp Ther 1996;279:106\u2013113.","journal-title":"J Pharmacol Exp Ther"},{"key":"94_CR14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02988264","volume":"17","author":"K. Ishiwata","year":"2003","unstructured":"Ishiwata K, Kobayashi T, Kawamura K, Matsuno K. Age-related changes of the binding of [3H]SA4503 to sigma1 receptors in the rat brain. Ann Nucl Med 2003;17:73\u201377.","journal-title":"Ann Nucl Med"},{"key":"94_CR15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0197-4580(02)00152-5","volume":"24","author":"K. Kawamura","year":"2003","unstructured":"Kawamura K, Kimura Y, Tsukada H, Kobayashi T, Nishiyama S, Kakiuchi T, et al. An increase of sigma receptors in the aged monkey brain. Neurobiol Aging 2003;24:745\u2013752.","journal-title":"Neurobiol Aging"},{"key":"94_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0006-3223(91)90209-5","volume":"29","author":"A.D. Weissman","year":"1991","unstructured":"Weissman AD, Casanova MF, Kleinman JE, London ED, De Souza EB. Selective loss of cerebral cortical sigma, but not PCP binding sites in schizophrenia. Biol Psychiatry 1991;29:41\u201354.","journal-title":"Biol Psychiatry"},{"key":"94_CR17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-2999(96)00497-9","volume":"312","author":"K. Matsuno","year":"1996","unstructured":"Matsuno K, Kobayashi T, Tanaka MK, Mita S. Sigma1 receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test. Eur J Pharmacol 1996;312:267\u2013271.","journal-title":"Eur J Pharmacol"},{"key":"94_CR18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0304-3940(90)90139-Z","volume":"117","author":"D. Lobner","year":"1990","unstructured":"Lobner D, Lipton P. Sigma-ligands and non-competitive NMDA antagonists inhibit glutamate release during cerebral ischemia. Neurosci Lett 1990;117:169\u2013174.","journal-title":"Neurosci Lett"},{"key":"94_CR19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0404.2005.00432.x","volume":"112","author":"M. Mishina","year":"2005","unstructured":"Mishina M, Ishiwata K, Ishii K, Kitamura S, Kimura Y, Kawamura K, et al. Function of sigma receptors in Parkinson\u2019s disease. Acta Neurol Scand 2005;112:103\u2013107.","journal-title":"Acta Neurol Scand"},{"key":"94_CR20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0006-8993(93)91441-T","volume":"623","author":"K.L. Jansen","year":"1993","unstructured":"Jansen KL, Faull RL, Storey P, Leslie RA. Loss of sigma binding sites in the CA1 area of the anterior hippocampus in Alzheimer\u2019s disease correlates with CA1 pyramidal cell loss. Brain Res 1993;623:299\u2013302.","journal-title":"Brain Res"},{"key":"94_CR21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1358\/dnp.2002.15.10.740241","volume":"15","author":"T. Maurice","year":"2002","unstructured":"Maurice T. Improving Alzheimer\u2019s disease-related cognitive deficits with sigma1 receptor agonists. Drug News Perspect 2002;15:617\u2013625.","journal-title":"Drug News Perspect"},{"key":"94_CR22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/syn.1046","volume":"40","author":"K. Ishiwata","year":"2001","unstructured":"Ishiwata K, Tsukada H, Kawamura K, Kimura Y, Nishiyama S, Kobayashi T, et al. Mapping of CNS sigma1 receptors in the conscious monkey: preliminary PET study with [11C]SA4503. Synapse 2001;40:235\u2013237.","journal-title":"Synapse"},{"key":"94_CR23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0969-8051(00)00081-0","volume":"27","author":"K. Kawamura","year":"2000","unstructured":"Kawamura K, Ishiwata K, Tajima H, Ishii S, Matsuno K, Homma Y, et al. In vivo evaluation of [11C]SA4503 as a PET ligand for mapping CNS sigma1 receptors. Nucl Med Biol 2000;27:255\u2013261.","journal-title":"Nucl Med Biol"},{"key":"94_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroimage.2006.11.055","volume":"35","author":"M. Sakata","year":"2007","unstructured":"Sakata M, Kimura Y, Naganawa M, Oda K, Ishii K, Chihara K, et al. Mapping of human cerebral sigma1 receptors using positron emission tomography and [11C]SA4503. Neuroimage 2007;35:1\u20138.","journal-title":"Neuroimage"},{"key":"94_CR25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G. McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 1984;34:939\u2013944.","journal-title":"Neurology"},{"key":"94_CR26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/nimg.2002.1208","volume":"17","author":"K. Herholz","year":"2002","unstructured":"Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frolich L, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002;17:302\u2013316.","journal-title":"Neuroimage"},{"key":"94_CR27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","volume":"42","author":"S. Minoshima","year":"1997","unstructured":"Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer\u2019s disease. Ann Neurol 1997;42:85\u201394.","journal-title":"Ann Neurol"},{"issue":"Suppl","key":"94_CR28","first-page":"9","volume":"48","author":"B. Reisberg","year":"1987","unstructured":"Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A. Behavioral symptoms in Alzheimer\u2019s disease: phenomenology and treatment. J Clin Psychiatry 1987;48Suppl:9\u201315.","journal-title":"J Clin Psychiatry"},{"key":"94_CR29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"M.F. Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-Mental State\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189\u2013198.","journal-title":"J Psychiatr Res"},{"key":"94_CR30","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","volume":"140","author":"C.P. Hughes","year":"1982","unstructured":"Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566\u2013572.","journal-title":"Br J Psychiatry"},{"key":"94_CR31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF03165298","volume":"11","author":"T. Fujiwara","year":"1997","unstructured":"Fujiwara T, Watanuki S, Yamamoto S, Miyake M, Seo S, Itoh M, et al. Performance evaluation of a large axial field-of-view PET scanner: SET-2400 W. Ann Nucl Med 1997;11:307\u2013313.","journal-title":"Ann Nucl Med"},{"key":"94_CR32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02987859","volume":"14","author":"M. Mishina","year":"2000","unstructured":"Mishina M, Senda M, Kimura Y, Toyama H, Ishiwata K, Ohyama M, et al. Intrasubject correlation between static scan and distribution volume images for [11C]flumazenil PET. Ann Nucl Med 2000;14:193\u2013198.","journal-title":"Ann Nucl Med"},{"key":"94_CR33","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0969-8051(03)00114-8","volume":"30","author":"J. Logan","year":"2003","unstructured":"Logan J. A review of graphical methods for tracer studies and strategies to reduce bias. Nucl Med Biol 2003;30:833\u2013844.","journal-title":"Nucl Med Biol"},{"key":"94_CR34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s004010050410","volume":"91","author":"R. Mielke","year":"1996","unstructured":"Mielke R, Schroder R, Fink GR, Kessler J, Herholz K, Heiss WD. Regional cerebral glucose metabolism and postmortem pathology in Alzheimer\u2019s disease. Acta Neuropathol (Berl) 1996;91:174\u2013179.","journal-title":"Acta Neuropathol (Berl)"},{"key":"94_CR35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF03164869","volume":"13","author":"M. Ohyama","year":"1999","unstructured":"Ohyama M, Senda M, Ishiwata K, Kitamura S, Mishina M, Ishii K, et al. Preserved benzodiazepine receptors in Alzheimer\u2019s disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF. Ann Nucl Med 1999;13:309\u2013315.","journal-title":"Ann Nucl Med"},{"key":"94_CR36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1474-4422(04)00853-1","volume":"3","author":"A. Nordberg","year":"2004","unstructured":"Nordberg A. PET imaging of amyloid in Alzheimer\u2019s disease. Lancet Neurol 2004;3:519\u2013527.","journal-title":"Lancet Neurol"},{"key":"94_CR37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0022-510X(89)90197-4","volume":"93","author":"H. Braak","year":"1989","unstructured":"Braak H, Braak E, Bohl J, Lang W. Alzheimer\u2019s disease: amyloid plaques in the cerebellum. J Neurol sci 1989;93:277\u2013287.","journal-title":"J Neurol sci"},{"key":"94_CR38","first-page":"925","volume":"38","author":"K. Ishii","year":"1997","unstructured":"Ishii K, Sasaki M, Kitagaki H, Yamaji S, Sakamoto S, Matsuda K, et al. Reduction of cerebellar glucose metabolism in advanced Alzheimer\u2019s disease. J Nucl Med 1997;38:925\u2013928.","journal-title":"J Nucl Med"},{"key":"94_CR39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000106632","volume":"8","author":"A.J. Larner","year":"1997","unstructured":"Larner AJ. The cerebellum in Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 1997;8:203\u2013209.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"94_CR40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0006-8993(98)01279-7","volume":"818","author":"J. Wegiel","year":"1999","unstructured":"Wegiel J, Wisniewski HM, Dziewiatkowski J, Badmajew E, Tarnawski M, Reisberg B, et al. Cerebellar atrophy in Alzheimer\u2019s disease-clinicopathological correlations. Brain Res 1999;818:41\u201350.","journal-title":"Brain Res"},{"key":"94_CR41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000051260","volume":"12","author":"M. Sj\u00f6beck","year":"2001","unstructured":"Sj\u00f6beck M, Englund E. Alzheimer\u2019s disease and the cerebellum: a morphologic study on neuronal and glial changes. Dement Geriatr Cogn Disord 2001;12:211\u2013218.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"94_CR42","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1212\/01.WNL.0000141848.45315.A6","volume":"63","author":"G. Verdile","year":"2004","unstructured":"Verdile G, Gnjec A, Miklossy J, Fonte J, Veurink G, Bates K, et al. Protein markers for Alzheimer disease in the frontal cortex and cerebellum. Neurology 2004;63:1385\u20131392.","journal-title":"Neurology"},{"key":"94_CR43","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.neurobiolaging.2005.09.021","volume":"27","author":"R. Sultana","year":"2006","unstructured":"Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB, et al. Redox proteomics identification of oxidized proteins in Alzheimer\u2019s disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol Aging 2006;27:1564\u20131576.","journal-title":"Neurobiol Aging"},{"key":"94_CR44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0197-0186(05)80005-1","volume":"33","author":"S. Chaki","year":"1998","unstructured":"Chaki S, Okuyama S, Ogawa S, Tomisawa K. Regulation of NMDA-induced [3H]dopamine release from rat hippocampal slices through sigma-1 binding sites. Neurochem Int 1998;33:29\u201334.","journal-title":"Neurochem Int"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-007-0094-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-007-0094-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-007-0094-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:41:46Z","timestamp":1559436106000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-007-0094-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["94"],"URL":"https:\/\/doi.org\/10.1007\/s12149-007-0094-z","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}